Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) - protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb)

Tengelmann, Caroline; Joos, Stefanie; Kaussner, Yvonne; Malzahn, Uwe; Lunden, Laura; Klug, Andreas; Hausler, Karl Georg; Escales, Catharina; Maetzler, Walter; Hugen, Klemens; Zolk, Oliver; Heuschmann, Peter U.; Forster, Christian; Kaduszkiewicz, Hanna; Gagyor, Ildiko

dc.contributor.author	Joos, Stefanie
dc.contributor.author	Förster, Christian
dc.date.accessioned	2024-07-29T08:24:17Z
dc.date.available	2024-07-29T08:24:17Z
dc.date.issued	2024
dc.identifier.issn	1471-2334
dc.identifier.uri	http://hdl.handle.net/10900/155847
dc.language.iso	en	de_DE
dc.publisher	London : Bmc	de_DE
dc.relation.uri	http://dx.doi.org/10.1186/s12879-023-08925-2	de_DE
dc.subject.ddc	610	de_DE
dc.title	Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) - protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb)	de_DE
dc.type	Article	de_DE
utue.quellen.id	20240422000000_00989
utue.personen.roh	Tengelmann, Caroline
utue.personen.roh	Joos, Stefanie
utue.personen.roh	Kaussner, Yvonne
utue.personen.roh	Malzahn, Uwe
utue.personen.roh	Lunden, Laura
utue.personen.roh	Klug, Andreas
utue.personen.roh	Hausler, Karl Georg
utue.personen.roh	Escales, Catharina
utue.personen.roh	Maetzler, Walter
utue.personen.roh	Hugen, Klemens
utue.personen.roh	Zolk, Oliver
utue.personen.roh	Heuschmann, Peter U.
utue.personen.roh	Forster, Christian
utue.personen.roh	Kaduszkiewicz, Hanna
utue.personen.roh	Gagyor, Ildiko
dcterms.isPartOf.ZSTitelID	Bmc Infectious Diseases	de_DE
dcterms.isPartOf.ZS-Issue	Article 56	de_DE
dcterms.isPartOf.ZS-Volume	24 (1)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE